Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily L Heil

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Infection Control and Hospital Epidemiology|January 19, 2018
Accuracy of Provider-Selected Indications for Antibiotic OrdersEmily L Heil, Lisa Pineles, Poonam Mathur, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous HemofiltrationWesley D Oliver, Emily L Heil, Jeffrey P Gonzales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2024
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative InfectionsPranita D Tamma, Emily L Heil, Julie Ann Justo, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2020
Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue InfectionsAlison L Blackman, Praneeth Jarugula, David P Nicolau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2018
Best Care for Patients Achieved Through Multidisciplinary StewardshipElizabeth Dodds Ashley, Susan L Davis, Emily L Heil, et al.
Diagnostic Microbiology and Infectious Disease|October 17, 2017
Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for EnterobacteriaceaeJacqueline T Bork, Emily L Heil, Surbhi Leekha, et al.
Currents in Pharmacy Teaching & Learning|December 1, 2019
Self-perceived knowledge and confidence regarding infectious diseases of advanced pharmacy practice experience studentsMelissa A Johnson, Bruce M Jones, Emily L Heil, et al.
Open Forum Infectious Diseases|December 27, 2023
Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A <i>Streptococcus</i> Skin and Soft Tissue InfectionsEmily L Heil, Harpreet Kaur, Anthony Atalla, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2018
The Cost of Self-Reported Penicillin Allergy: A Systematic ReviewT Joseph Mattingly, Anne Fulton, Rachel A Lumish, et al.
Open Forum Infectious Diseases|October 6, 2016
Implementation of an Infectious Disease Fellow-Managed Penicillin Allergy Skin Testing ServiceEmily L Heil, Jacqueline T Bork, Sarah A Schmalzle, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Infection Control and Hospital Epidemiology|January 19, 2018
Accuracy of Provider-Selected Indications for Antibiotic OrdersEmily L Heil, Lisa Pineles, Poonam Mathur, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous HemofiltrationWesley D Oliver, Emily L Heil, Jeffrey P Gonzales, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 7, 2024
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative InfectionsPranita D Tamma, Emily L Heil, Julie Ann Justo, et al.
Antimicrobial Agents and Chemotherapy|December 1, 2020
Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue InfectionsAlison L Blackman, Praneeth Jarugula, David P Nicolau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2018
Best Care for Patients Achieved Through Multidisciplinary StewardshipElizabeth Dodds Ashley, Susan L Davis, Emily L Heil, et al.
Diagnostic Microbiology and Infectious Disease|October 17, 2017
Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for EnterobacteriaceaeJacqueline T Bork, Emily L Heil, Surbhi Leekha, et al.
Currents in Pharmacy Teaching & Learning|December 1, 2019
Self-perceived knowledge and confidence regarding infectious diseases of advanced pharmacy practice experience studentsMelissa A Johnson, Bruce M Jones, Emily L Heil, et al.
Open Forum Infectious Diseases|December 27, 2023
Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A <i>Streptococcus</i> Skin and Soft Tissue InfectionsEmily L Heil, Harpreet Kaur, Anthony Atalla, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2018
The Cost of Self-Reported Penicillin Allergy: A Systematic ReviewT Joseph Mattingly, Anne Fulton, Rachel A Lumish, et al.
Open Forum Infectious Diseases|October 6, 2016
Implementation of an Infectious Disease Fellow-Managed Penicillin Allergy Skin Testing ServiceEmily L Heil, Jacqueline T Bork, Sarah A Schmalzle, et al.
Pageof 12